Assessment of effectiveness of percutaneous laser ablation (PLA) in cirrhotic patients with hepatocellular carcinoma (HCC) submitted to liver transplantation (LT)

被引：0
|
作者：
Pompili, M. [1 ]
Nicolardi, E. [1 ]
Francica, G. [2 ]
Petrolati, A.
Angelico, M.
Tisone, G.
Santeusanio, G. [3 ]
Craboledda, P. [4 ]
Marino, B. [4 ]
Rossi, Z.
Pacella, S. [5 ]
Rapaccini, G. L. [1 ]
Gasbarrini, G. [1 ]
Pacella, C. M. [5 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Med Interna & Geriart, Rome, Italy
[2] Osped S Maria Della Pieta, Unit Ecografia Operat, Casoria, Italy
[3] Univ Roma Tor Vergata, Dipartimento Patol, I-00173 Rome, Italy
[4] Osped S Eugenio, UOC Anat Istol Patol, Rome, Italy
[5] Osped Regina Apostolorum, Dipartimento Diagnost Immagini & Radiol Intervent, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2007年 / 39卷 / 10期
关键词：
D O I：
10.1016/j.dld.2007.07.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A36 / A36
页数：1
相关论文
共 50 条
  • [21] Evaluation of percutaneous ablation treatments of hepatocellular carcinoma (HCC) as a risk factor for neoplastic recurrence in patients who underwent liver transplant (LT).
    Mirante, G
    Pompili, M
    Rondinara, G
    Forti, D
    Rossi, G
    Fassati, LR
    Agnes, S
    Castagneto, M
    Pelecca, G
    Gasbarrini, G
    Rapaccini, GL
    HEPATOLOGY, 2003, 38 (04) : 376A - 377A
  • [22] PERCUTANEOUS RADIOFREQUENCY (PRFA) AS A BRIDGE TO LIVER TRANSPLANTATION (LT) FOR HEPATOCELLULAR CARCINOMA (HCC): CLINICO-PATHOLOGICAL RESULTS
    Smail, A.
    Adam, R.
    Sebagh, M.
    Vibert, E.
    Salloum, C.
    Perdigao, F.
    Azoulay, D.
    Samuel, D.
    Guettier, C.
    Castaing, D.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S256 - S256
  • [23] Laser ablation: an alternative to radiofrequency ablation for hepatocellular carcinoma in cirrhotic patients?
    Pacella, Claudio Maurizio
    Francica, Giampiero
    Di Costanzo, Giovan Giuseppe
    HEPATIC ONCOLOGY, 2015, 2 (02) : 111 - 115
  • [24] EFFICACY AND SAFETY OF PERCUTANEOUS LASER ABLATION (PLA) IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) LOCATED AT HARD-TO-TREAT SITES
    Petrolati, A.
    Stasi, R.
    Nasoni, S.
    Rossi, Z.
    Pacella, C. M.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S104 - S105
  • [25] NATURAL HISTORY OF RECURRENT HEPATOCELLULAR CARCINOMA (HCC) AFTER LIVER TRANSPLANTATION (LT)
    Dharancy, S.
    Hollebeeque, A.
    Boleslawski, E.
    Declerck, N.
    Canva, V.
    Mathurin, P.
    Pruvot, F. R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S129 - S129
  • [26] Role of Immunosuppression (IS) in the Recurrence of Hepatocellular Carcinoma (HCC) after Liver Transplantation (LT)
    Lai, Q.
    Graziadei, I
    Pinheiro, R. S.
    Vogel, W.
    Lerut, J.
    TRANSPLANTATION, 2012, 94 (10) : 757 - 757
  • [27] THE IMPACT OF HEPATOCELLULAR CARCINOMA (HCC) ON LIVER TRANSPLANTATION (LT) IN THE UNITED STATES (US)
    Younossi, Zobair M.
    Harring, Michael
    Kabbara, Khaled W.
    Eberly, Katherine Elizabeth
    Younossi, Youssef
    Ong, Janus
    Alqahtani, Saleh
    Stepanova, Maria
    HEPATOLOGY, 2021, 74 : 908A - 909A
  • [28] Assessment of percutaneous treatments in patients with hepatocellular carcinoma before liver transplantation
    Yaghi, C
    Durand, F
    Vilgrain, V
    Degott, C
    Sauvanet, A
    Farges, O
    Bernau, J
    Belghiti, J
    Valla, D
    TRANSPLANTATION, 1999, 67 (07) : S17 - S17
  • [29] Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation
    Lu, DSK
    Yu, NC
    Raman, SS
    Lassman, C
    Tong, MJ
    Britten, C
    Durazo, F
    Saab, S
    Han, S
    Finn, R
    Hiatt, JR
    Busuttil, RW
    HEPATOLOGY, 2005, 41 (05) : 1130 - 1137
  • [30] Percutaneous ablation of hepatocellular carcinoma as a bridge to liver transplantation.
    Alwan, AJA
    Kachura, J
    Ho, CS
    Grant, DR
    Cattral, MS
    McGilvary, I
    Sherman, M
    Walsh, M
    Shah, S
    Girgrah, N
    Lilly, L
    Levy, GA
    Greig, PD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 428 - 429
12345